464 related articles for article (PubMed ID: 25793500)
21. Sp1/Sp3 binding is associated with cell-specific expression of the glucose-dependent insulinotropic polypeptide receptor gene.
Boylan MO; Jepeal LI; Wolfe MM
Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1287-95. PubMed ID: 16403775
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
Lok CN; Lang AJ; Mirski SE; Cole SP
Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
[TBL] [Abstract][Full Text] [Related]
23. Evolution of Sp transcription factors.
Kolell KJ; Crawford DL
Mol Biol Evol; 2002 Mar; 19(3):216-22. PubMed ID: 11861880
[TBL] [Abstract][Full Text] [Related]
24. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
Rotheneder H; Geymayer S; Haidweger E
J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
[TBL] [Abstract][Full Text] [Related]
25. Regulation of transcription of the Dnmt1 gene by Sp1 and Sp3 zinc finger proteins.
Kishikawa S; Murata T; Kimura H; Shiota K; Yokoyama KK
Eur J Biochem; 2002 Jun; 269(12):2961-70. PubMed ID: 12071960
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of human topoisomerase IIalpha expression correlates with relative amounts of specificity factors Sp1 and Sp3 bound at proximal and distal promoter regions.
Williams AO; Isaacs RJ; Stowell KM
BMC Mol Biol; 2007 May; 8():36. PubMed ID: 17511886
[TBL] [Abstract][Full Text] [Related]
27. Differential transcriptional regulation of c-myc promoter through the same DNA binding sites targeted by Sp1-like proteins.
Majello B; De Luca P; Suske G; Lania L
Oncogene; 1995 May; 10(9):1841-8. PubMed ID: 7753559
[TBL] [Abstract][Full Text] [Related]
28. Functional significance of Sp1, Sp2, and Sp3 transcription factors in regulation of the murine CTP:phosphocholine cytidylyltransferase alpha promoter.
Bakovic M; Waite KA; Vance DE
J Lipid Res; 2000 Apr; 41(4):583-94. PubMed ID: 10744779
[TBL] [Abstract][Full Text] [Related]
29. Accessible chromatin structure permits factors Sp1 and Sp3 to regulate human TGFBI gene expression.
Lee JJ; Park K; Shin MH; Yang WJ; Song MJ; Park JH; Yong TS; Kim EK; Kim HP
Biochem Biophys Res Commun; 2011 Jun; 409(2):222-8. PubMed ID: 21554857
[TBL] [Abstract][Full Text] [Related]
30. Activator protein-2 mediates transcriptional activation of the CYP11A1 gene by interaction with Sp1 rather than binding to DNA.
Pena P; Reutens AT; Albanese C; D'Amico M; Watanabe G; Donner A; Shu IW; Williams T; Pestell RG
Mol Endocrinol; 1999 Aug; 13(8):1402-16. PubMed ID: 10446912
[TBL] [Abstract][Full Text] [Related]
31. Structural and functional characterization of the mouse tescalcin promoter.
Perera EM; Bao Y; Kos L; Berkovitz G
Gene; 2010 Sep; 464(1-2):50-62. PubMed ID: 20540995
[TBL] [Abstract][Full Text] [Related]
32. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
Lou Z; Maher VM; McCormick JJ
Gene; 2005 May; 351():51-9. PubMed ID: 15857802
[TBL] [Abstract][Full Text] [Related]
33. Isolation and characterization of the human A-myb promoter: regulation by NF-Y and Sp1.
Facchinetti V; Lopa R; Spreafico F; Bolognese F; Mantovani R; Tavner F; Watson R; Introna M; Golay J
Oncogene; 2000 Aug; 19(34):3931-40. PubMed ID: 10951586
[TBL] [Abstract][Full Text] [Related]
34. Transactivation of the progesterone receptor gene in granulosa cells: evidence that Sp1/Sp3 binding sites in the proximal promoter play a key role in luteinizing hormone inducibility.
Sriraman V; Sharma SC; Richards JS
Mol Endocrinol; 2003 Mar; 17(3):436-49. PubMed ID: 12554796
[TBL] [Abstract][Full Text] [Related]
35. Transcription of the LAT gene is regulated by multiple binding sites for Sp1 and Sp3.
Whitten C; Swygert S; Butler SE; Finco TS
Gene; 2008 Apr; 413(1-2):58-66. PubMed ID: 18343609
[TBL] [Abstract][Full Text] [Related]
36. Contrasting mammalian parathyroid hormone (PTH) promoters: nuclear factor-Y binds to a deoxyribonucleic acid element unique to the human PTH promoter and acts as a transcriptional enhancer.
Alimov AP; Langub MC; Malluche HH; Park-Sarge OK; Koszewski NJ
Endocrinology; 2004 Jun; 145(6):2713-20. PubMed ID: 15001549
[TBL] [Abstract][Full Text] [Related]
37. Laminin reduces expression of the human alpha6 integrin subunit gene by altering the level of the transcription factors Sp1 and Sp3.
Gaudreault M; Vigneault F; Leclerc S; Guérin SL
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3490-505. PubMed ID: 17652716
[TBL] [Abstract][Full Text] [Related]
38. Characterization of human cathepsin L promoter and identification of binding sites for NF-Y, Sp1 and Sp3 that are essential for its activity.
Jean D; Guillaume N; Frade R
Biochem J; 2002 Jan; 361(Pt 1):173-84. PubMed ID: 11742542
[TBL] [Abstract][Full Text] [Related]
39. CpG methylation and transcription factors Sp1 and Sp3 regulate the expression of the human secretin receptor gene.
Pang RT; Lee LT; Ng SS; Yung WH; Chow BK
Mol Endocrinol; 2004 Feb; 18(2):471-83. PubMed ID: 14645499
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the 5'-flanking region of the human transcription factor Sp3 gene.
Tapias A; Monasterio P; Ciudad CJ; Noé V
Biochim Biophys Acta; 2005 Aug; 1730(2):126-36. PubMed ID: 16024108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
